REPLY
- PMID: 32895966
- DOI: 10.1002/hep.31542
REPLY
Comment on
-
Incidence, risk factors, and prognosis of abnormal liver biochemical tests in COVID-19 patients: a systematic review and meta-analysis.Hepatol Int. 2020 Sep;14(5):621-637. doi: 10.1007/s12072-020-10074-6. Epub 2020 Jul 24. Hepatol Int. 2020. PMID: 32710250 Free PMC article.
-
Letter to the Editor: Liver Biochemistries in Hospitalized Chinese Patients With Severe Coronavirus Disease 2019.Hepatology. 2021 May;73(5):2079-2080. doi: 10.1002/hep.31541. Hepatology. 2021. PMID: 32901451 No abstract available.
References
-
- Wu Y, Li H, Guo X, Yoshida EM, Mendez-Sanchez N, Sandri GBL, et al. Incidence, risk factors, and prognosis of abnormal liver biochemical tests in COVID-19 patients: a systematic review and meta-analysis. Hepatol Int 2020 Jul 24. https://doi.org/10.1007/s12072-020-10074-6. [Epub ahead of print]
-
- Kulkarni AV, Kumar P, Tevethia HV, Premkumar M, Arab JP, Candia R, et al. Systematic review with meta-analysis: liver manifestations and outcomes in COVID-19. Aliment Pharmacol Ther 2020;52:584-599.
-
- Youssef M, Hussein MH, Attia AS, Elshazli RM, Omar M, Zora G, et al. COVID-19 and liver dysfunction: a systematic review and meta-analysis of retrospective studies. J Med Virol 2020 May 23. https://doi.org/10.1002/jmv.26055. [Epub ahead of print]
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
